A genome-wide approach to the characterisation of human and murine DNA methylation. (360G-Wellcome-084358_B_07_Z)

£107,120

The proposed project is designed to assay methylation mutants in mouse and humanusing genomic microarray technology. Offspring of mice lacking DNA methyltransferase 3L (Dnmt3L) have no maternal methylation marks at imprinted loci. Genomic array technology will be used to compare mice lacking maternally derived Dnmt3L with wildtype, to identify novel regions of differential methylation and associated imprinted genes. A subset of human patients with transient neonatal diabetes (TNDM) lack maternal methylation marks at a number of imprinted loci. Furthermore, about 30% of patients with SRS show reduced methylation at the H19 DMR. DNA from these patients, like in TNDM, could also be hypomethylated at other loci, providing a rationale for their investigation. We will use methylation-specific array technology to compare a hypomethylated SRS and TNDM samples with control individuals. We will validate regions of novel differential methylation by bisulphite sequencing analysis and confirm novel imprinted genes using allele-specific assays.

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Amount Awarded 107120
Applicant Surname Moore
Approval Committee Molecules, Genes and Cells Funding Committee
Award Date 2008-02-20T00:00:00+00:00
Financial Year 2007/08
Grant Programme: Title Project Grant
Internal ID 084358/B/07/Z
Lead Applicant Prof Gudrun Moore
Other Applicant(s) Prof Rebecca Oakey
Partnership Value 107120
Planned Dates: End Date 2012-02-22T00:00:00+00:00
Planned Dates: Start Date 2009-02-23T00:00:00+00:00
Recipient Org: Country United Kingdom
Region Greater London